Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Norway / NCT05681858
Recruiting Observational

Plaque Burden and Ischemia in MINOCA

NCT05681858 · tracked via the Priya Life Science Norway tracker
Sponsor
University of Bergen
Phase
Observational
Started
2023-08-15
Last updated
2023-12-04

Condition(s) studied

MINOCA

Investigational drug(s) / intervention(s)

CT coronary angiography and [12N] NH3 PET-MR

CT coronary angiography and [12N] NH3 PET-MR: Advanced coronary artery plaque analysis, myocardial ischemia and coronary flow reserve

Study summary

The goal of this clinical trial is to assess coronary artery plaque burden, perivascular inflammation and extent of myocardial ischemia in patients presenting with acute myocardial infarction and non-obstructive coronary artery disease. The main question it aims to answer are:

* Identify coronary artery anatomy, plaque burden, composition and high-risk plaque features by CT coronary angiography in MINOCA
* Assess presence, extent and severity of myocardial ischemia in MINOCA

Participants will examined by CT coronary angiography and stress \[12N\] NH3 PET-MR.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Acute chest pain * Elevated troponin * Non-obstructive coronary arteries by coronary angiography Exclusion Criteria: * Obstructive coronary artery disease * Contraindications against CT coronary angiography or stress \[12N\] NH3 PET-MR * Not able to give informed consent

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Clinical Science, University of Bergen Bergen Norway Recruiting

More University of Bergen trials in Norway

Coronary Artery Plaque Burden in Stable Angina and Non-obstructive Coronary Artery Disease Active, not recruiting
Screening and Stimulation Testing for Residual Secretion of Adrenal Steroid Hormones in Autoimmune Addison's Disease Active, not recruiting
Virtual Darkness Theraphy for Agitation in Dementia Recruiting
A Brief Intervention for PTSD - BWRT Enrolling by invitation
Effect of Herring Oil Concentrate on LDL Cholesterol Concentration in Adults Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05681858 on ClinicalTrials.gov ↗ ← All trials in Norway